Global Pulmonary Surfactant Market Growth 2024-2030

Global Pulmonary Surfactant Market Growth 2024-2030

Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.

The global Pulmonary Surfactant market size is projected to grow from US$ 566.4 million in 2023 to US$ 779.5 million in 2030; it is expected to grow at a CAGR of 4.7% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Pulmonary Surfactant Industry Forecast” looks at past sales and reviews total world Pulmonary Surfactant sales in 2023, providing a comprehensive analysis by region and market sector of projected Pulmonary Surfactant sales for 2024 through 2030. With Pulmonary Surfactant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Surfactant industry.

This Insight Report provides a comprehensive analysis of the global Pulmonary Surfactant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Surfactant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pulmonary Surfactant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Surfactant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Surfactant.

Increasing prevalence of respiratory infections are attributing to the highest share of North America market in the global pulmonary surfactant market

This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Surfactant market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Synthetic Pulmonary Surfactants
Animal Derived Surfactants

Segmentation by application
Hospital
laboratory
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pulmonary Surfactant market?

What factors are driving Pulmonary Surfactant market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pulmonary Surfactant market opportunities vary by end market size?

How does Pulmonary Surfactant break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.